Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Wed, 04.06.2025
Redcare Pharmacy N.V.
Statement on today’s media coverage regarding CardLink.
Today’s publications in the media referred to structural changes in the way e-prescriptions will be redeemed digitally from April 2026. Those publications do not contain any new information. In August 2024, gematik published a technical concept outlining the so-called PoPP solution (Proof of [ … ]
Fri, 16.05.2025
Redcare Pharmacy N.V.
Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.
Sevenum, the Netherlands, 16 May, 2025. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of M [ … ]
Tue, 06.05.2025
Redcare Pharmacy N.V.
Strong Q1 performance for Redcare Pharmacy: back to a positive margin while maintaining fast growth.
Total sales increased 28% to EUR 717M; non-Rx sales up 20% to EUR 484M, Rx sales in Germany up 191% to EUR 108M.
Adj. EBITDA improved EUR 14M vs. the prior quarter to EUR +9M and the margin from -0.7% to 1.3%; prior year, adj. EBITDA of EUR 12M, ma [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Fri, 04.04.2025
Redcare Pharmacy N.V.
Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
Group sales up 28% or EUR 157M year over year, to EUR 717M in Q1.
Rx sales in Germany up 191% to EUR 108M.
Non-Rx sales up 20% to EUR 484M.
Active customer base up 0.6M in Q1 to 13.1M, 1.9M higher in [ … ]
Wed, 02.04.2025
Redcare Pharmacy N.V.
Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.
Sevenum, 2 April 2025. At Redcare Pharmacy’s upcoming Annual General Meeting (AGM) on 15 May 2025, changes to the composition of the Supervisory Board will be on the agenda. Redcare Pharmacy nominates the company’s founders and former board members Michael Kö [ … ]
Tue, 11.03.2025
Redcare Pharmacy N.V.
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
Total sales +32% to EUR 2.4 bn in FY 2024 (Q4, +27%), with DACH +33% (Q4, 27%) and International +26% (Q4, 29%). Non-Rx sales +21% to EUR 1.6 bn (Q4, +22%).
Record gain in active customers, up 1.7M to 12.5M, with Ger [ … ]
Thu, 27.02.2025
Redcare Pharmacy N.V.
Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers.
Sevenum, the Netherlands, 27 February 2025 – Redcare Pharmacy welcomes today's judgment of the European Court of Justice that advertising measures that promote the purchase of prescription medicines in the form of direct discounts or [ … ]